PrEP Case Consultation

Slides:



Advertisements
Similar presentations
Recommendations for STD Clinical Preventive Services for Persons Living with HIV/AIDS.
Advertisements

PrEP: HIV Pre-exposure Prophylaxis Katherine Marx, MS, MPH, FNP-BC June 2014.
Utilization and Quality of STD Services in Managed Care Organizations: A Synthesis of Recent Research K Irwin 1, W Lafferty 2, ER Brown 3, N Pourat 3,
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
HIV in Texas: The Ways Forward Ann Robbins Manager of HIV/STD Prevention and Care Department of State Health Services.
HIV Prophylaxis: Following Occupational and Non-Occupational Exposure Nanik (Nayri) Hatsakorzian Pharm.D./MPH candidate 2014 Touro University, College.
Potential role of PEP, PrEP and ART for HIV Prevention among Men who have Sex with Men Frits van Griensven, PhD, MPH Division of HIV/AIDS Prevention US.
DC American Academy of Pediatrics Adolescent Health Working Group Expedited Partner Therapy Fact Sheet Updated February 20, 2014 DC American Academy of.
BLOOD BORNE PATHOGEN EXPOSURE Management – What you need to know about Needlesticks and Splashes Amy J. Behrman, MD Occupational Medicine Dept of Emergency.
New York State Department of Health AIDS Institute June, 2014
STD Testing Protocols, STD Testing, and Discussion of Sexual Behaviors in HIV Clinics in Los Angeles County Melanie M. Taylor MD, MPH Los Angeles County.
Managing Hepatitis C: An Unprecedented Correctional Healthcare Challenge ASCA/CCHA meeting Phoenix, AZ RADM Newton E. Kendig Assistant Director/Medical.
N ORTHWEST AIDS E DUCATION AND T RAINING C ENTER PrEP 201: Beyond the Basics Joanne Stekler, MD MPH Associate Professor of Medicine University of Washington.
Antiretroviral Postexposure Prophylaxis after Sexual, Injection Drug Use, or Other Nonoccupational Exposure to HIV in the United States Recommendations.
Case 1: 23-year-old Male Student Clinical Director, Division of Infectious Diseases Brigham and Women’s Hospital Professor of Medicine Harvard Medical.
Introduction to NCHHSTP National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Office of the Director Jonathan Mermin, MD, MPH National.
Michael Hughes, MD Assistant Clinical Professor UCR Eisenhower Medical Associates.
SPECIAL CONSIDERATIONS August
1 MSM Sexual Health Summit August 20, 2012 HIV/STD Prevention and Care Branch Texas Department of State Health Services.
Pharmacist-Managed HIV Pre-Exposure Prophylaxis (PrEP) Clinic: Preliminary Outcomes From an Urban Community Health Clinic Mark T. Sawkin, PharmD, AAHIVP.
PrEP Update: The science, new tools, and next steps Dawn K. Smith MD, MS, MPH Division of HIV/AIDS Prevention, CDC “The findings and conclusions in this.
N ORTHWEST A IDS E DUCATION AND T RAINING C ENTER Pre-exposure Prophylaxis for HIV Prevention Efficacy and the importance of adherence Joanne Stekler,
A pill to prevent HIV? For women??
Paying for Sexual and Reproductive Health Services for PLWHA Jennifer Marshall Pepper Program & Quality Manager, Ryan White Part A Program Shelby County.
STI didn’t know that…. Treatment STI Prevention Symptoms What it is?
Expanded PrEP implementation across Australia Expanded implementation of PrEP across Australia 1.
Expanded PrEP implementation in NSW (EPIC-NSW) 1 AIDS 2016 | 22 July 2016.
Pre-exposure Prophylaxis (PrEP) for HIV Prevention: What’s the Future? Joanne Stekler, MD MPH Assistant Professor of Medicine University of Washington.
Hepatitis C Consultation Services (844) | 9AM-5PM ET, M-F nccc.ucsf.edu The Clinician Consultation Center (CCC) provides up-to-date expert clinical.
PrEP and PEP for HIV: Before and After Prevention
PrEP, medication to prevent HIV
Providing PrEP – The Basics
Pre-exposure Prophylaxis for HIV Prevention
Pacific AIDS Education and Training Center
Information about HIV Prevention Options
HIV Prevention By Theo Hodge, Jr. MD for
State Office of AIDS Update
PrEP for HIV Prevention
Adolescent Support Services in Zambia
Focus on Providers: Identifying and Training PrEP Providers
Women and Clinical Trials (presented in Haitian Creole) Welcome!
Preexposure Prophylaxis (PreP) for the Prevention of HIV
Module 4 (c) Stopping PrEP
Methods: One-Step PrEP®
Pharmacokinetics: HIV Drugs
PrEP as an HIV Prevention Tool in Queer Communities of Color: Barriers and Opportunities BACKGROUND Joanne Stekler, MD MPH.
On Demand PrEP for Men at High Risk for HIV IPERGAY
Module 4 (a) Getting started on PrEP
Pharmacokinetics: HIV Drugs
Alyson Decker, NP, MPH Clinical Prevention Consultant
Hepatitis C Consultation Services (844) | 9AM-8PM EST, M-F nccc.ucsf.edu The Clinician Consultation Center (CCC) provides up-to-date expert advice.
Do Patients adherent on PrEP exposed to HIV have seroconversion symptoms & falsely reactive HIV tests? Mark Roche1, Elaney Youssef1, Yvonne Gilleece¹,
David Magnuson, Trevor Hawkins, Robertino Mera
One pill a day, can keep HIV away
Prescribing PrEP to adolescents and young adults
Pre-Exposure Prophylaxis (PrEP) for HIV Infection
PrEP.
An Update from CROI and the Changing Landscape of HIV in NZ
From Start to Finish: Initial and Ongoing Care for Men Receiving PrEP
100 Partners PrEP[5] Efficacy 75% Adherence 81% 80
PrEP for HIV Prevention
HIV.
HIV nPEP* Process Algorithm - DRAFT
PrEP for HIV Prevention
Lesson 3: Treatment as Prevention
PrEP in Brazil: 18 months of implementation as a public health policy
HIV Testing- What’s Your Routine?
Bob Holtkamp, Director of Prevention & Outreach
PrEP to Prevent HIV and Promote Sexual Health
PrEP Education and Counseling in a Title X Setting
Presentation transcript:

PrEP Case Consultation Susanne Doblecki-Lewis, MD Associate Professor of Clinical Medicine Division of Infectious Diseases University of Miami Miller School of Medicine November 30, 2016

Biomedical HIV Prevention… that Works PrEP PEP ART Prior to exposure Time of transmission After infection

Where are We Now - Prevention 2.0 Using PrEP to Prevent Transmission McCormack S, et al. Lancet. 2016 Jan 2; 387(10013); 53-60; Molina JM, et al. N Engl J Med. 2015 Dec 3; (373)2237-2246; Baeten J, et al. CROI 2015 Feb 23-26; abstract 24.

PrEP Use Has Escalated Quickly Data from: Rawlings K et al. (McCallister S presenting) FTC/TDF (Truvada) for HIV pre-exposure prophylaxis (PrEP) utilization in the United States: 2013-2015. 21st International AIDS Conference, Durban, abstract TUAX0105LB, 2016.

A Variety of Providers are Involved in PrEP Care Physician providers: Family Medicine, Internal Medicine, Pediatrics, Ob/Gyn, Infectious Diseases Nurse Practitioners & Physician Assistants in many settings RNs (100% efficacy in SF project with 700 men) Pharmacists (Seattle project)

PrEP is Prescribed in a Variety of Settings Municipal STD Clinics Sexual Health and Wellness Clinics Community Health Centers Federally Qualified Health Centers HIV-Treatment Centers

Some Questions for Today How to choose nPEP or PrEP? How to transition from nPEP to PrEP? How to pay for PrEP?

Biomedical HIV Prevention PEP PrEP ART Prior to exposure Time of transmission After infection 72 hours

PEP Implementation PEP is time sensitive Need to begin medication ASAP, <72 hours Important to get baseline testing for HIV, also HBV and HCV, STIs Preferably HIV Ag/Ab test if available http://www.cdc.gov/hiv/pdf/programresources/cdc-hiv-npep-guidelines.pdf

HIV Testing and Detection of HIV http://www.rnceus.com/fl2hiv/test2.html (accessed Nov 2016)

PEP – What to Give Give 3 drugs for 28 days Recheck HIV test Tenofovir/Emtricitabine/Raltegravir Tenofovir/Emtricitabine/Dolutegravir Tenofovir/Emtricitabine/Darunavir/Ritonavir Recheck HIV test 4-6 weeks 3 months 6 months http://www.cdc.gov/hiv/pdf/programresources/cdc-hiv-npep-guidelines.pdf

How to Give nPEP If possible, give a “Starter Pack” of 3-5 days of meds, or the entire 28 day course This requires supply of medication on hand in the clinic or pharmacy Adherence may be better when whole 28 day course is given Two drug nPEP is not recommended in current guidelines http://www.cdc.gov/hiv/pdf/programresources/cdc-hiv-npep-guidelines.pdf

How to Pay for nPEP Commercial insurance covers nPEP May have high copay Need to communicate urgency by phone Medicaid will cover nPEP Patient Assistance Programs, likely multiple Good resource for process for PAPs for nPEP: https://www.health.ny.gov/diseases/aids/providers/standards/docs/payment_options_npep.pdf

Case A 33 year old man presents 24 hours after an episode of condomless receptive anal intercourse with a man who he subsequently learned was HIV positive. He states that he has had 10 partners in the last 6 months and uses condoms inconsistently. He has a history of rectal gonorrhea and secondary syphilis within the last year.

Questions Is he a good candidate for nPEP? What about PrEP?

Source: http://www.cdc.gov/hiv/policies/law/risk.html

This is a good candidate for PrEP due to repeated exposure (not just one episode) However, had a high risk exposure within last 72 hours, so nPEP is indicated

Start nPEP Baseline rapid HIV test is negative Start 3-drug nPEP HIV Ag/Ab test is negative Re-test at 4 weeks

4 Week Post-Exposure HIV Ag/Ab repeat test is negative Can transition directly to PrEP without gap http://www.cdc.gov/hiv/pdf/programresources/cdc-hiv-npep-guidelines.pdf

How to Give PrEP? Creatinine (CrCl > 60 mg/dl) Hepatitis B serology (vaccinate if neg) Pregnancy test for women Baseline HIV test Evaluate for symptoms of acute HIV infection

What to Prescribe? Tenofovir/Emtricitabine (Truvada®) is the only FDA approved drug for PrEP One tablet daily is the only approved dosing strategy Pre/Post Coital dosing is NOT recommended Prescribe up to a 90 day supply http://www.cdc.gov/hiv/pdf/prepguidelines2014.pdf

Side Effects & What to Expect Side-effects are generally minimal Occasional GI upset that usually resolves in 1-2 weeks Renal dysfunction is rare and reverses with discontinuation. Bone mineral density decrease may occur but clinical significance is unclear 7 days needed to achieve protective levels in rectal mucosa 21 days for women

How to Follow a Patient on PrEP? Quarterly check-ins for HIV testing, side effects, counseling, prescription Creatinine at 3 months & every 6 months if OK STD testing every 6 months http://www.cdc.gov/hiv/pdf/prepguidelines2014.pdf

www.projectinform.org/pre-chart (in English and Spanish)

Thanks for Attending Guidelines are available to answer many questions: http://www.cdc.gov/hiv/pdf/prepguidelines2014.pdf http://www.hivguidelines.org/ PrEPline 855-448-7737 at the National Clinician Consultation Center http://nccc.ucsf.edu/clinician- consultation/prep-pre-exposure-prophylaxis/